Nelson Cephixime Capsule (Cephixime Hydrate)

Adult dose

(Capsules) Adults: Administer 50～100mg (potency) of cefixime orally twice daily. For severe infections or when the response is inadequate, administer 200mg (potency) twice daily. The dose may be adjusted as appropriate according to age and symptoms.

Child dose

(Capsules) Children weighing 30 Kg or more: Administer 50～100mg (potency) of cefixime orally twice daily. For severe infections or when the response is inadequate, administer 200mg (potency) twice daily. The dose may be adjusted as appropriate according to age and symptoms. (Powder) Children: Administer 1.5～3mg (potency) of cefixime per Kg of body weight orally twice daily. For severe infections or when the response is inadequate, administer 6mg (potency) per Kg of body weight twice daily. The dose may be adjusted as appropriate according to age and symptoms.

This medication should not be used in certain patients. For example, patients who have experienced shock due to this medication, those allergic to cephalosporin antibiotics, and patients with genetic disorders that affect lactose digestion should not take this medication. Additionally, those with a history of allergy to this medication or similar drugs, patients sensitive to penicillin antibiotics, people with allergic predispositions, and patients with severely impaired renal function should use this medication with caution. This medication can rarely cause serious side effects, so if symptoms such as discomfort, dizziness, difficulty breathing, rash, severe diarrhea, interstitial pneumonia, blood abnormalities, skin disorders, liver dysfunction, or kidney issues occur, discontinue use immediately and consult a physician. While using this medication, it is important to take it for the minimum required period to prevent the emergence of resistant bacteria, and to confirm whether there has been a history of shock reactions. Caution is advised when taking this medication along with warfarin due to an increased risk of bleeding, as well as when combined with other drugs that may induce renal toxicity. The safety of this medication in pregnant or lactating women has not been established, so it should only be used when necessary, and breastfeeding should be avoided. It is not recommended for neonates or infants under 6 months as safety has not been confirmed. Elderly patients may experience more side effects due to decreased body function, so careful observation and adjustments of dosage and intervals are necessary. This medication may affect test results, so care should be taken during urinalysis or blood tests. Lastly, the suspension of this medication should not be stored for more than 2 weeks after preparation, and the powdered form should not be left in milk or juice for long periods.

Shock

This medication should be stored in a tightly sealed container to prevent air from entering, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage maintains the medication's efficacy and prevents degradation.

Appearance

Hard orange capsules, upper and lower parts containing white to light yellow crystalline powder

Package unit

30 capsules/bottle, 100 capsules/bottle